Spectrum Pharmaceuticals logo
Spectrum Pharmaceuticals SPPI
report update icon

Quarterly report 2023-Q1
added 11-21-2026

Spectrum Pharmaceuticals Total Current Liabilities | SPPI

Annual Total Current Liabilities Spectrum Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
42.7 M 53.2 M 53.1 M 62 M 98.3 M 110 M 65.5 M 76.3 M 109 M 90 M 123 M 78.5 M 63.3 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
123 M 42.7 M 78.9 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
7.97 M $ 1.04 -4.59 % $ 32.4 M usaUSA
Oncternal Therapeutics Oncternal Therapeutics
ONCT
5.2 M - -24.12 % $ 1.56 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
16.1 M - - $ 401 M usaUSA
Histogen Histogen
HSTO
1.23 M - 31.6 % $ 2.12 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
125 M - -7.23 % $ 13 M usaUSA
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
386 M - - $ 1.62 B israelIsrael
Omeros Corporation Omeros Corporation
OMER
78.1 M $ 13.23 -5.71 % $ 840 M usaUSA
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
27.9 M - 7.4 % $ 6.29 M usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
35.1 M - - $ 958 M usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
261 M - - $ 8.14 B usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
949 M - - $ 26.6 B irlandaIrlanda
Provention Bio Provention Bio
PRVB
90.4 M - - $ 2.37 B usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
59 M - - $ 6.29 B usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
2.44 M $ 0.47 -24.53 % $ 305 K israelIsrael
iTeos Therapeutics iTeos Therapeutics
ITOS
40.4 M - - $ 411 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 1.44 -2.03 % $ 2.37 M israelIsrael
PolarityTE PolarityTE
PTE
2.07 M - -0.82 % $ 1.78 M usaUSA
Kronos Bio Kronos Bio
KRON
15.3 M - 1.49 % $ 50.8 M usaUSA
Cullinan Management Cullinan Management
CGEM
37.7 M $ 8.9 -1.93 % $ 536 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
149 M $ 39.15 0.57 % $ 3.52 B schweizSchweiz
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
57.9 M $ 26.77 -0.59 % $ 1.59 B usaUSA
Trevena Trevena
TRVN
7.55 M - -46.58 % $ 31.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
7.39 M - -10.95 % $ 876 K usaUSA
Molecular Templates Molecular Templates
MTEM
17.3 M - -23.43 % $ 495 K usaUSA
Oncorus Oncorus
ONCR
37.2 M - -8.54 % $ 3.19 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
53.9 M $ 0.07 9.81 % $ 855 K usaUSA
Novan Novan
NOVN
46.4 M - -24.84 % $ 2.64 M usaUSA
CohBar CohBar
CWBR
1.69 M - -15.44 % $ 2.2 M usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
2.15 M - -1.56 % $ 12.3 M usaUSA
Epizyme Epizyme
EPZM
45.2 M - - $ 249 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
7.45 M - -48.37 % $ 3.71 M usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
27.6 M - - $ 4.55 M irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
3.64 M $ 0.71 -3.81 % $ 14.6 M usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
14.9 M - - $ 218 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
9.71 M - - $ 105 M usaUSA
Athersys Athersys
ATHX
38.4 M - 3.77 % $ 22.4 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
88 M - - $ 4.62 B usaUSA
Inozyme Pharma Inozyme Pharma
INZY
33.9 M - - $ 207 M usaUSA
NanoString Technologies NanoString Technologies
NSTG
58.9 M - -37.43 % $ 5.1 M usaUSA
Humanigen Humanigen
HGEN
56.2 M - -81.12 % $ 4.28 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
4.1 M $ 3.56 -9.07 % $ 1.58 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
328 M - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
16.3 M - - $ 59.7 M usaUSA
Sierra Oncology Sierra Oncology
SRRA
12.9 M - -0.05 % $ 1.34 B canadaCanada
Vaccinex Vaccinex
VCNX
5.08 M - -61.37 % $ 654 K usaUSA